Abstract
Summary
Pentobarbital Sodium Injection is a sterile solution for intravenous or intramuscular injection. Pentobarbital Sodium Injection is a short-acting barbiturate, chemically designated as sodium 5-ethyl-5-(1-methylbutyl) barbiturate. The barbiturates are nonselective central nervous system depressants which are primarily used as sedative hypnotics and also anticonvulsants in subhypnotic doses.
The global market for Pentobarbital Sodium Injection was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Pentobarbital Sodium Injection was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pentobarbital Sodium Injection was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Pentobarbital Sodium Injection was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Pentobarbital Sodium Injection include Leucadia Pharmaceuticals, SAGENT Pharmaceuticals, Martindale Pharma, Bioveta and Akorn Pharmaceuticals, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pentobarbital Sodium Injection, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Pentobarbital Sodium Injection by region & country, by Type, and by Application.
The Pentobarbital Sodium Injection market size, estimations, and forecasts are provided in terms of sales volume (KL) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pentobarbital Sodium Injection.
Market Segmentation
By Company
Leucadia Pharmaceuticals
SAGENT Pharmaceuticals
Martindale Pharma
Bioveta
Akorn Pharmaceuticals
Segment by Type:
1000mg/20mL
2500mg/50mL
Segment by Application
Adult Use
Pediatric Use
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Pentobarbital Sodium Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Pentobarbital Sodium Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Pentobarbital Sodium Injection in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Pentobarbital Sodium Injection was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Pentobarbital Sodium Injection was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pentobarbital Sodium Injection was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Pentobarbital Sodium Injection was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Pentobarbital Sodium Injection include Leucadia Pharmaceuticals, SAGENT Pharmaceuticals, Martindale Pharma, Bioveta and Akorn Pharmaceuticals, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pentobarbital Sodium Injection, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Pentobarbital Sodium Injection by region & country, by Type, and by Application.
The Pentobarbital Sodium Injection market size, estimations, and forecasts are provided in terms of sales volume (KL) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pentobarbital Sodium Injection.
Market Segmentation
By Company
Leucadia Pharmaceuticals
SAGENT Pharmaceuticals
Martindale Pharma
Bioveta
Akorn Pharmaceuticals
Segment by Type:
1000mg/20mL
2500mg/50mL
Segment by Application
Adult Use
Pediatric Use
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Pentobarbital Sodium Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Pentobarbital Sodium Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Pentobarbital Sodium Injection in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Pentobarbital Sodium Injection Product Introduction
1.2 Global Pentobarbital Sodium Injection Market Size Forecast
1.2.1 Global Pentobarbital Sodium Injection Sales Value (2019-2030)
1.2.2 Global Pentobarbital Sodium Injection Sales Volume (2019-2030)
1.2.3 Global Pentobarbital Sodium Injection Sales Price (2019-2030)
1.3 Pentobarbital Sodium Injection Market Trends & Drivers
1.3.1 Pentobarbital Sodium Injection Industry Trends
1.3.2 Pentobarbital Sodium Injection Market Drivers & Opportunity
1.3.3 Pentobarbital Sodium Injection Market Challenges
1.3.4 Pentobarbital Sodium Injection Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Pentobarbital Sodium Injection Players Revenue Ranking (2023)
2.2 Global Pentobarbital Sodium Injection Revenue by Company (2019-2024)
2.3 Global Pentobarbital Sodium Injection Players Sales Volume Ranking (2023)
2.4 Global Pentobarbital Sodium Injection Sales Volume by Company Players (2019-2024)
2.5 Global Pentobarbital Sodium Injection Average Price by Company (2019-2024)
2.6 Key Manufacturers Pentobarbital Sodium Injection Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Pentobarbital Sodium Injection Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Pentobarbital Sodium Injection
2.9 Pentobarbital Sodium Injection Market Competitive Analysis
2.9.1 Pentobarbital Sodium Injection Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Pentobarbital Sodium Injection Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pentobarbital Sodium Injection as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 1000mg/20mL
3.1.2 2500mg/50mL
3.2 Global Pentobarbital Sodium Injection Sales Value by Type
3.2.1 Global Pentobarbital Sodium Injection Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Pentobarbital Sodium Injection Sales Value, by Type (2019-2030)
3.2.3 Global Pentobarbital Sodium Injection Sales Value, by Type (%) (2019-2030)
3.3 Global Pentobarbital Sodium Injection Sales Volume by Type
3.3.1 Global Pentobarbital Sodium Injection Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Pentobarbital Sodium Injection Sales Volume, by Type (2019-2030)
3.3.3 Global Pentobarbital Sodium Injection Sales Volume, by Type (%) (2019-2030)
3.4 Global Pentobarbital Sodium Injection Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Adult Use
4.1.2 Pediatric Use
4.2 Global Pentobarbital Sodium Injection Sales Value by Application
4.2.1 Global Pentobarbital Sodium Injection Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Pentobarbital Sodium Injection Sales Value, by Application (2019-2030)
4.2.3 Global Pentobarbital Sodium Injection Sales Value, by Application (%) (2019-2030)
4.3 Global Pentobarbital Sodium Injection Sales Volume by Application
4.3.1 Global Pentobarbital Sodium Injection Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Pentobarbital Sodium Injection Sales Volume, by Application (2019-2030)
4.3.3 Global Pentobarbital Sodium Injection Sales Volume, by Application (%) (2019-2030)
4.4 Global Pentobarbital Sodium Injection Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Pentobarbital Sodium Injection Sales Value by Region
5.1.1 Global Pentobarbital Sodium Injection Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Pentobarbital Sodium Injection Sales Value by Region (2019-2024)
5.1.3 Global Pentobarbital Sodium Injection Sales Value by Region (2025-2030)
5.1.4 Global Pentobarbital Sodium Injection Sales Value by Region (%), (2019-2030)
5.2 Global Pentobarbital Sodium Injection Sales Volume by Region
5.2.1 Global Pentobarbital Sodium Injection Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Pentobarbital Sodium Injection Sales Volume by Region (2019-2024)
5.2.3 Global Pentobarbital Sodium Injection Sales Volume by Region (2025-2030)
5.2.4 Global Pentobarbital Sodium Injection Sales Volume by Region (%), (2019-2030)
5.3 Global Pentobarbital Sodium Injection Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Pentobarbital Sodium Injection Sales Value, 2019-2030
5.4.2 North America Pentobarbital Sodium Injection Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Pentobarbital Sodium Injection Sales Value, 2019-2030
5.5.2 Europe Pentobarbital Sodium Injection Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Pentobarbital Sodium Injection Sales Value, 2019-2030
5.6.2 Asia Pacific Pentobarbital Sodium Injection Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Pentobarbital Sodium Injection Sales Value, 2019-2030
5.7.2 South America Pentobarbital Sodium Injection Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Pentobarbital Sodium Injection Sales Value, 2019-2030
5.8.2 Middle East & Africa Pentobarbital Sodium Injection Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Pentobarbital Sodium Injection Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Pentobarbital Sodium Injection Sales Value
6.2.1 Key Countries/Regions Pentobarbital Sodium Injection Sales Value, 2019-2030
6.2.2 Key Countries/Regions Pentobarbital Sodium Injection Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Pentobarbital Sodium Injection Sales Value, 2019-2030
6.3.2 United States Pentobarbital Sodium Injection Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Pentobarbital Sodium Injection Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Pentobarbital Sodium Injection Sales Value, 2019-2030
6.4.2 Europe Pentobarbital Sodium Injection Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Pentobarbital Sodium Injection Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Pentobarbital Sodium Injection Sales Value, 2019-2030
6.5.2 China Pentobarbital Sodium Injection Sales Value by Type (%), 2023 VS 2030
6.5.3 China Pentobarbital Sodium Injection Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Pentobarbital Sodium Injection Sales Value, 2019-2030
6.6.2 Japan Pentobarbital Sodium Injection Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Pentobarbital Sodium Injection Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Pentobarbital Sodium Injection Sales Value, 2019-2030
6.7.2 South Korea Pentobarbital Sodium Injection Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Pentobarbital Sodium Injection Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Pentobarbital Sodium Injection Sales Value, 2019-2030
6.8.2 Southeast Asia Pentobarbital Sodium Injection Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Pentobarbital Sodium Injection Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Pentobarbital Sodium Injection Sales Value, 2019-2030
6.9.2 India Pentobarbital Sodium Injection Sales Value by Type (%), 2023 VS 2030
6.9.3 India Pentobarbital Sodium Injection Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Leucadia Pharmaceuticals
7.1.1 Leucadia Pharmaceuticals Company Information
7.1.2 Leucadia Pharmaceuticals Introduction and Business Overview
7.1.3 Leucadia Pharmaceuticals Pentobarbital Sodium Injection Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Leucadia Pharmaceuticals Pentobarbital Sodium Injection Product Offerings
7.1.5 Leucadia Pharmaceuticals Recent Development
7.2 SAGENT Pharmaceuticals
7.2.1 SAGENT Pharmaceuticals Company Information
7.2.2 SAGENT Pharmaceuticals Introduction and Business Overview
7.2.3 SAGENT Pharmaceuticals Pentobarbital Sodium Injection Sales, Revenue and Gross Margin (2019-2024)
7.2.4 SAGENT Pharmaceuticals Pentobarbital Sodium Injection Product Offerings
7.2.5 SAGENT Pharmaceuticals Recent Development
7.3 Martindale Pharma
7.3.1 Martindale Pharma Company Information
7.3.2 Martindale Pharma Introduction and Business Overview
7.3.3 Martindale Pharma Pentobarbital Sodium Injection Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Martindale Pharma Pentobarbital Sodium Injection Product Offerings
7.3.5 Martindale Pharma Recent Development
7.4 Bioveta
7.4.1 Bioveta Company Information
7.4.2 Bioveta Introduction and Business Overview
7.4.3 Bioveta Pentobarbital Sodium Injection Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Bioveta Pentobarbital Sodium Injection Product Offerings
7.4.5 Bioveta Recent Development
7.5 Akorn Pharmaceuticals
7.5.1 Akorn Pharmaceuticals Company Information
7.5.2 Akorn Pharmaceuticals Introduction and Business Overview
7.5.3 Akorn Pharmaceuticals Pentobarbital Sodium Injection Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Akorn Pharmaceuticals Pentobarbital Sodium Injection Product Offerings
7.5.5 Akorn Pharmaceuticals Recent Development
8 Industry Chain Analysis
8.1 Pentobarbital Sodium Injection Industrial Chain
8.2 Pentobarbital Sodium Injection Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Pentobarbital Sodium Injection Sales Model
8.5.2 Sales Channel
8.5.3 Pentobarbital Sodium Injection Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer